{"entity":{"type":"insider","cik":"0001298033","url":"/insider/0001298033","json_url":"/insider/0001298033.json","name":"Domain Partners VI, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":33,"first":"2010-04-27","last":"2016-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Domain Partners VI, L.P.","source":"filing","n_filings":33,"first_seen":"2010-04-27","last_seen":"2016-08-03"}],"transactions":[{"id":2544398,"accession":"0000904454-16-001352","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001352","line_url":"/filing/0000904454-16-001352#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81094.0,"shares_display":"81,094","price_per_share":8.15,"price_display":"8.15","price_state":"stated","total_value":660916.1,"total_display":"660,916.10","total_whole":"660,916","shares_owned_after":1943109.0,"shares_owned_after_display":"1,943,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-03","filed_date":"2016-08-03","scope":"insider"},{"id":2544394,"accession":"0000904454-16-001352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001352","line_url":"/filing/0000904454-16-001352#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19718.0,"shares_display":"19,718","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":171743.78,"total_display":"171,743.78","total_whole":"171,744","shares_owned_after":2024203.0,"shares_owned_after_display":"2,024,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-02","filed_date":"2016-08-03","scope":"insider"},{"id":2544386,"accession":"0000904454-16-001352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001352","line_url":"/filing/0000904454-16-001352#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52216.0,"shares_display":"52,216","price_per_share":8.82,"price_display":"8.82","price_state":"stated","total_value":460545.12,"total_display":"460,545.12","total_whole":"460,545","shares_owned_after":2043921.0,"shares_owned_after_display":"2,043,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":3200474,"accession":"0000904454-16-001196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001196","line_url":"/filing/0000904454-16-001196#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; Domain Partners VI, L.P.","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149765.0,"shares_display":"149,765","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":1042364.4,"total_display":"1,042,364.40","total_whole":"1,042,364","shares_owned_after":2096137.0,"shares_owned_after_display":"2,096,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-28","filed_date":"2016-05-02","scope":"insider"},{"id":6924657,"accession":"0000904454-14-000567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000567","line_url":"/filing/0000904454-14-000567#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; Domain Partners VI, L.P.; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":419744.0,"shares_display":"419,744","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":3357952.0,"total_display":"3,357,952.00","total_whole":"3,357,952","shares_owned_after":2476886.0,"shares_owned_after_display":"2,476,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":6453170,"accession":"0000904454-14-000083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000083","line_url":"/filing/0000904454-14-000083#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; Domain Partners VI, L.P.; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204315.0,"shares_display":"204,315","price_per_share":6.56,"price_display":"6.56","price_state":"stated","total_value":1340306.4,"total_display":"1,340,306.40","total_whole":"1,340,306","shares_owned_after":3590931.0,"shares_owned_after_display":"3,590,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-17","scope":"insider"},{"id":6453162,"accession":"0000904454-14-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-14-000083","line_url":"/filing/0000904454-14-000083#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; Domain Partners VI, L.P.; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92445.0,"shares_display":"92,445","price_per_share":6.01,"price_display":"6.01","price_state":"stated","total_value":555594.45,"total_display":"555,594.45","total_whole":"555,594","shares_owned_after":3795246.0,"shares_owned_after_display":"3,795,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":4902446,"accession":"0000904454-13-000985","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000904454-13-000985","line_url":"/filing/0000904454-13-000985#line-5","is_derivative":false,"issuer_cik":"0001298033","issuer_name":"Regado Biosciences Inc","issuer_ticker":"RGDO","issuer_name_source":null,"issuer_url":"/issuer/0001298033","owner_cik":"0001298033","owner_name":"Domain Partners VI, L.P.","owner_display_name":"Domain Partners VI, L.P.","owner_url":"/insider/0001298033","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":2571117.0,"shares_owned_after_display":"2,571,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-27","filed_date":"2013-08-28","scope":"insider"},{"id":9206227,"accession":"0000904454-13-000863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000863","line_url":"/filing/0000904454-13-000863#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001298033","owner_name":"Domain Partners VI, L.P.","owner_display_name":"Domain Partners VI, L.P.","owner_url":"/insider/0001298033","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":331873.0,"shares_display":"331,873","price_per_share":6.0264,"price_display":"6.03","price_state":"stated","total_value":1999999.4472,"total_display":"1,999,999.45","total_whole":"1,999,999","shares_owned_after":1857036.0,"shares_owned_after_display":"1,857,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-31","scope":"insider"},{"id":5275569,"accession":"0000904454-13-000826","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000826","line_url":"/filing/0000904454-13-000826#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001298033","owner_name":"Domain Partners VI, L.P.","owner_display_name":"Domain Partners VI, L.P.","owner_url":"/insider/0001298033","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":331873.0,"shares_display":"331,873","price_per_share":6.0264,"price_display":"6.03","price_state":"stated","total_value":1999999.4472,"total_display":"1,999,999.45","total_whole":"1,999,999","shares_owned_after":1897336.0,"shares_owned_after_display":"1,897,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-16","scope":"insider"},{"id":4902362,"accession":"0000904454-13-000715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000715","line_url":"/filing/0000904454-13-000715#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; TREU JESSE I; Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10516.0,"shares_display":"10,516","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":52685.16,"total_display":"52,685.16","total_whole":"52,685","shares_owned_after":3887691.0,"shares_owned_after_display":"3,887,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-20","filed_date":"2013-06-24","scope":"insider"},{"id":4713200,"accession":"0000904454-13-000711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000711","line_url":"/filing/0000904454-13-000711#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; VITULLO NICOLE; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22423.0,"shares_display":"22,423","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":120411.51,"total_display":"120,411.51","total_whole":"120,412","shares_owned_after":3898207.0,"shares_owned_after_display":"3,898,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-19","filed_date":"2013-06-20","scope":"insider"},{"id":4713186,"accession":"0000904454-13-000711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000711","line_url":"/filing/0000904454-13-000711#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; VITULLO NICOLE; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32855.0,"shares_display":"32,855","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":177417.0,"total_display":"177,417.00","total_whole":"177,417","shares_owned_after":3920630.0,"shares_owned_after_display":"3,920,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-18","filed_date":"2013-06-20","scope":"insider"},{"id":4515601,"accession":"0000904454-13-000701","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000701","line_url":"/filing/0000904454-13-000701#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87812.0,"shares_display":"87,812","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":474184.8,"total_display":"474,184.80","total_whole":"474,185","shares_owned_after":3953485.0,"shares_owned_after_display":"3,953,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-18","scope":"insider"},{"id":4515596,"accession":"0000904454-13-000701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000701","line_url":"/filing/0000904454-13-000701#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38897.0,"shares_display":"38,897","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":195651.91,"total_display":"195,651.91","total_whole":"195,652","shares_owned_after":4041297.0,"shares_owned_after_display":"4,041,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-18","scope":"insider"},{"id":5435130,"accession":"0000904454-13-000689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000689","line_url":"/filing/0000904454-13-000689#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; Domain Partners VI, L.P.; TREU JESSE I","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5337.0,"shares_display":"5,337","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":26685.0,"total_display":"26,685.00","total_whole":"26,685","shares_owned_after":4080194.0,"shares_owned_after_display":"4,080,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-11","filed_date":"2013-06-13","scope":"insider"},{"id":4902343,"accession":"0000904454-13-000582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000582","line_url":"/filing/0000904454-13-000582#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; Domain Partners VI, L.P.","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21276.0,"shares_display":"21,276","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":95742.0,"total_display":"95,742.00","total_whole":"95,742","shares_owned_after":4085531.0,"shares_owned_after_display":"4,085,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-16","filed_date":"2013-05-17","scope":"insider"},{"id":4902340,"accession":"0000904454-13-000582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000582","line_url":"/filing/0000904454-13-000582#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; Domain Partners VI, L.P.","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22966.0,"shares_display":"22,966","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":107940.2,"total_display":"107,940.20","total_whole":"107,940","shares_owned_after":4106807.0,"shares_owned_after_display":"4,106,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider"},{"id":4620276,"accession":"0000904454-13-000492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000492","line_url":"/filing/0000904454-13-000492#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; DOVEY BRIAN H; TREU JESSE I; Domain Partners VI, L.P.; VITULLO NICOLE","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71578.0,"shares_display":"71,578","price_per_share":6.62,"price_display":"6.62","price_state":"stated","total_value":473846.36,"total_display":"473,846.36","total_whole":"473,846","shares_owned_after":7313241.0,"shares_owned_after_display":"7,313,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-15","filed_date":"2013-04-17","scope":"insider"},{"id":4475302,"accession":"0000904454-13-000488","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-13-000488","line_url":"/filing/0000904454-13-000488#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Domain Partners VI, L.P.; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4832.0,"shares_display":"4,832","price_per_share":6.72,"price_display":"6.72","price_state":"stated","total_value":32471.04,"total_display":"32,471.04","total_whole":"32,471","shares_owned_after":7384819.0,"shares_owned_after_display":"7,384,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-10","filed_date":"2013-04-10","scope":"insider"},{"id":4475301,"accession":"0000904454-13-000488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000488","line_url":"/filing/0000904454-13-000488#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Domain Partners VI, L.P.; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35114.0,"shares_display":"35,114","price_per_share":6.71,"price_display":"6.71","price_state":"stated","total_value":235614.94,"total_display":"235,614.94","total_whole":"235,615","shares_owned_after":7389651.0,"shares_owned_after_display":"7,389,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-09","filed_date":"2013-04-10","scope":"insider"},{"id":4475296,"accession":"0000904454-13-000488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000488","line_url":"/filing/0000904454-13-000488#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Domain Partners VI, L.P.; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37676.0,"shares_display":"37,676","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":245647.52,"total_display":"245,647.52","total_whole":"245,648","shares_owned_after":7424765.0,"shares_owned_after_display":"7,424,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-08","filed_date":"2013-04-10","scope":"insider"},{"id":4956314,"accession":"0000904454-13-000471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000471","line_url":"/filing/0000904454-13-000471#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; BLAIR JAMES C; Domain Partners VI, L.P.; DOVEY BRIAN H; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13490.0,"shares_display":"13,490","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":72171.5,"total_display":"72,171.50","total_whole":"72,172","shares_owned_after":7462441.0,"shares_owned_after_display":"7,462,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-21","filed_date":"2013-03-22","scope":"insider"},{"id":5402818,"accession":"0000904454-13-000457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000457","line_url":"/filing/0000904454-13-000457#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16995.0,"shares_display":"16,995","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":88713.9,"total_display":"88,713.90","total_whole":"88,714","shares_owned_after":7475931.0,"shares_owned_after_display":"7,475,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-20","filed_date":"2013-03-21","scope":"insider"},{"id":5402815,"accession":"0000904454-13-000457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000457","line_url":"/filing/0000904454-13-000457#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24442.0,"shares_display":"24,442","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":126853.98,"total_display":"126,853.98","total_whole":"126,854","shares_owned_after":7492926.0,"shares_owned_after_display":"7,492,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-19","filed_date":"2013-03-21","scope":"insider"},{"id":5095834,"accession":"0000904454-13-000447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000447","line_url":"/filing/0000904454-13-000447#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24736.0,"shares_display":"24,736","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":127637.76,"total_display":"127,637.76","total_whole":"127,638","shares_owned_after":7517368.0,"shares_owned_after_display":"7,517,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-19","scope":"insider"},{"id":5095829,"accession":"0000904454-13-000447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000447","line_url":"/filing/0000904454-13-000447#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29719.0,"shares_display":"29,719","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":156916.32,"total_display":"156,916.32","total_whole":"156,916","shares_owned_after":7542104.0,"shares_owned_after_display":"7,542,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-19","scope":"insider"},{"id":4515545,"accession":"0000904454-13-000437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000437","line_url":"/filing/0000904454-13-000437#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; DOVEY BRIAN H; Domain Partners VI, L.P.","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15480.0,"shares_display":"15,480","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":82972.8,"total_display":"82,972.80","total_whole":"82,973","shares_owned_after":7571823.0,"shares_owned_after_display":"7,571,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-15","scope":"insider"},{"id":4515541,"accession":"0000904454-13-000437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000437","line_url":"/filing/0000904454-13-000437#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; DOVEY BRIAN H; Domain Partners VI, L.P.","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23848.0,"shares_display":"23,848","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":128779.2,"total_display":"128,779.20","total_whole":"128,779","shares_owned_after":7587303.0,"shares_owned_after_display":"7,587,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-13","filed_date":"2013-03-15","scope":"insider"},{"id":4902323,"accession":"0000904454-13-000429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000429","line_url":"/filing/0000904454-13-000429#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE; DOVEY BRIAN H; Domain Partners VI, L.P.; BLAIR JAMES C","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19569.0,"shares_display":"19,569","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":105281.22,"total_display":"105,281.22","total_whole":"105,281","shares_owned_after":7611151.0,"shares_owned_after_display":"7,611,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-13","scope":"insider"},{"id":4902317,"accession":"0000904454-13-000429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000429","line_url":"/filing/0000904454-13-000429#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE; DOVEY BRIAN H; Domain Partners VI, L.P.; BLAIR JAMES C","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12700.0,"shares_display":"12,700","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":67818.0,"total_display":"67,818.00","total_whole":"67,818","shares_owned_after":7630720.0,"shares_owned_after_display":"7,630,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-13","scope":"insider"},{"id":4666467,"accession":"0000904454-13-000401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000401","line_url":"/filing/0000904454-13-000401#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; Domain Partners VI, L.P.; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15892.0,"shares_display":"15,892","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":84545.44,"total_display":"84,545.44","total_whole":"84,545","shares_owned_after":7643420.0,"shares_owned_after_display":"7,643,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-08","filed_date":"2013-03-11","scope":"insider"},{"id":4666463,"accession":"0000904454-13-000401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000401","line_url":"/filing/0000904454-13-000401#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; Domain Partners VI, L.P.; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39168.0,"shares_display":"39,168","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":204456.96,"total_display":"204,456.96","total_whole":"204,457","shares_owned_after":7659312.0,"shares_owned_after_display":"7,659,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-07","filed_date":"2013-03-11","scope":"insider"},{"id":4380581,"accession":"0000904454-13-000397","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000397","line_url":"/filing/0000904454-13-000397#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; Domain Partners VI, L.P.; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11841.0,"shares_display":"11,841","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":59915.46,"total_display":"59,915.46","total_whole":"59,915","shares_owned_after":7698480.0,"shares_owned_after_display":"7,698,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-07","scope":"insider"},{"id":4380569,"accession":"0000904454-13-000397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000397","line_url":"/filing/0000904454-13-000397#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; Domain Partners VI, L.P.; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12454.0,"shares_display":"12,454","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":62394.54,"total_display":"62,394.54","total_whole":"62,395","shares_owned_after":7710321.0,"shares_owned_after_display":"7,710,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-07","scope":"insider"},{"id":4431055,"accession":"0000904454-13-000374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000374","line_url":"/filing/0000904454-13-000374#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; Domain Partners VI, L.P.","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15865.0,"shares_display":"15,865","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":79483.65,"total_display":"79,483.65","total_whole":"79,484","shares_owned_after":7722775.0,"shares_owned_after_display":"7,722,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-04","filed_date":"2013-03-05","scope":"insider"},{"id":4431049,"accession":"0000904454-13-000374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000374","line_url":"/filing/0000904454-13-000374#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; Domain Partners VI, L.P.","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23548.0,"shares_display":"23,548","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":117975.48,"total_display":"117,975.48","total_whole":"117,975","shares_owned_after":7738640.0,"shares_owned_after_display":"7,738,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-05","scope":"insider"},{"id":4572949,"accession":"0000904454-13-000321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000321","line_url":"/filing/0000904454-13-000321#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Domain Partners VI, L.P.; TREU JESSE I; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; BLAIR JAMES C","owner_display_name":"Domain Partners VI, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6160.0,"shares_display":"6,160","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":30861.6,"total_display":"30,861.60","total_whole":"30,862","shares_owned_after":7762188.0,"shares_owned_after_display":"7,762,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-20","filed_date":"2013-02-22","scope":"insider"},{"id":5463291,"accession":"0000904454-13-000307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000307","line_url":"/filing/0000904454-13-000307#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; Domain Partners VI, L.P.; TREU JESSE I; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31075.0,"shares_display":"31,075","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":155996.5,"total_display":"155,996.50","total_whole":"155,997","shares_owned_after":7768348.0,"shares_owned_after_display":"7,768,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-20","scope":"insider"},{"id":5463287,"accession":"0000904454-13-000307","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000307","line_url":"/filing/0000904454-13-000307#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; Domain Partners VI, L.P.; TREU JESSE I; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9148.0,"shares_display":"9,148","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":45740.0,"total_display":"45,740.00","total_whole":"45,740","shares_owned_after":7799423.0,"shares_owned_after_display":"7,799,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-15","filed_date":"2013-02-20","scope":"insider"},{"id":4713124,"accession":"0000904454-13-000293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000293","line_url":"/filing/0000904454-13-000293#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Domain Partners VI, L.P.; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9100.0,"shares_display":"9,100","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":45591.0,"total_display":"45,591.00","total_whole":"45,591","shares_owned_after":7808571.0,"shares_owned_after_display":"7,808,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-14","filed_date":"2013-02-15","scope":"insider"},{"id":4713110,"accession":"0000904454-13-000293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000293","line_url":"/filing/0000904454-13-000293#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Domain Partners VI, L.P.; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17770.0,"shares_display":"17,770","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":88850.0,"total_display":"88,850.00","total_whole":"88,850","shares_owned_after":7817671.0,"shares_owned_after_display":"7,817,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-13","filed_date":"2013-02-15","scope":"insider"},{"id":4666448,"accession":"0000904454-13-000165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000165","line_url":"/filing/0000904454-13-000165#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE; Domain Partners VI, L.P.; BLAIR JAMES C","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30134.0,"shares_display":"30,134","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":146149.9,"total_display":"146,149.90","total_whole":"146,150","shares_owned_after":7835441.0,"shares_owned_after_display":"7,835,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-05","scope":"insider"},{"id":4515531,"accession":"0000904454-13-000154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000154","line_url":"/filing/0000904454-13-000154#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; Domain Partners VI, L.P.","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57165.0,"shares_display":"57,165","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":269247.15,"total_display":"269,247.15","total_whole":"269,247","shares_owned_after":7865575.0,"shares_owned_after_display":"7,865,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-31","filed_date":"2013-02-01","scope":"insider"},{"id":4515528,"accession":"0000904454-13-000154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000154","line_url":"/filing/0000904454-13-000154#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; Domain Partners VI, L.P.","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34248.0,"shares_display":"34,248","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":171240.0,"total_display":"171,240.00","total_whole":"171,240","shares_owned_after":7922740.0,"shares_owned_after_display":"7,922,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-30","filed_date":"2013-02-01","scope":"insider"},{"id":5349902,"accession":"0000904454-13-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000142","line_url":"/filing/0000904454-13-000142#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; Domain Partners VI, L.P.; VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47247.0,"shares_display":"47,247","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":248991.69,"total_display":"248,991.69","total_whole":"248,992","shares_owned_after":7956988.0,"shares_owned_after_display":"7,956,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-29","filed_date":"2013-01-30","scope":"insider"},{"id":5349899,"accession":"0000904454-13-000142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000142","line_url":"/filing/0000904454-13-000142#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; Domain Partners VI, L.P.; VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51377.0,"shares_display":"51,377","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":277435.8,"total_display":"277,435.80","total_whole":"277,436","shares_owned_after":8004235.0,"shares_owned_after_display":"8,004,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-30","scope":"insider"},{"id":9206201,"accession":"0000904454-13-000134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000134","line_url":"/filing/0000904454-13-000134#line-2","is_derivative":false,"issuer_cik":"0001196863","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001196863","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42525.0,"shares_display":"42,525","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":228784.5,"total_display":"228,784.50","total_whole":"228,785","shares_owned_after":8055612.0,"shares_owned_after_display":"8,055,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-29","scope":"insider"},{"id":4572932,"accession":"0000904454-13-000130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000130","line_url":"/filing/0000904454-13-000130#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; Domain Partners VI, L.P.; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42525.0,"shares_display":"42,525","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":228784.5,"total_display":"228,784.50","total_whole":"228,785","shares_owned_after":8055612.0,"shares_owned_after_display":"8,055,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-28","scope":"insider"},{"id":9206202,"accession":"0000904454-13-000134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000134","line_url":"/filing/0000904454-13-000134#line-1","is_derivative":false,"issuer_cik":"0001196863","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001196863","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; Domain Partners VI, L.P.; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112022.0,"shares_display":"112,022","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":610519.9,"total_display":"610,519.90","total_whole":"610,520","shares_owned_after":8098137.0,"shares_owned_after_display":"8,098,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-24","filed_date":"2013-01-29","scope":"insider"}],"collapsed":true,"next_cursor":"2013-01-24|9206202","ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Ten percent owner","n_filings":2,"first_seen":"2016-05-02","last_seen":"2016-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001267813","name":"MARINUS PHARMACEUTICALS INC","url":"/issuer/0001267813","role":"Ten percent owner","n_filings":1,"first_seen":"2014-08-07","last_seen":"2014-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Ten percent owner","n_filings":7,"first_seen":"2010-04-27","last_seen":"2014-01-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001311596","name":"Regado Biosciences Inc","url":"/issuer/0001311596","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-28","last_seen":"2013-08-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-16","last_seen":"2013-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":20,"first_seen":"2013-01-22","last_seen":"2013-04-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298033","retrieved_at":"2026-08-27T10:28:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}